Loading clinical trials...
Loading clinical trials...
A Phase 1b, Multi-cohort Clinical Trial Assessing Safety and Feasibility of Exercise and Spermidine Administered in Conjunction With Lamivudine (RTi) or Rapamycin (mTORi) to Assess Impact on Dynamic Changes of Inflammation and Aging
Conditions
Interventions
lamivudine
rapamycin
+2 more
Locations
1
United States
Mount Sinai Hospital
New York, New York, United States
Start Date
August 25, 2025
Primary Completion Date
July 1, 2026
Completion Date
July 1, 2026
Last Updated
September 25, 2025
NCT06818032
NCT04252781
NCT07261176
NCT01678118
NCT03031145
NCT02585791
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions